Catalponol enhances dopamine biosynthesis and protects against l-DOPA-induced cytotoxicity in PC12 cells

The effects of catalponol (1) on dopamine biosynthesis and l-DOPA-induced cytotoxicity in PC12 cells were investigated. Catalponol at concentration ranges of 1–5 μM increased the intracellular levels of dopamine at 12–48 h. Catalponol at concentrations of up to 10 μM did not alter cell viability. Tyrosine hydroxylase (TH) activity was enhanced by 1 at 3 μM in a time-dependent manner, but aromatic l-amino acid decarboxylase activity was not. Catalponol also increased the intracellular levels of cyclic AMP and TH phosphorylation. In addition, catalponol at 3 μM associated with l-DOPA (20–50 μM) further enhanced the increases in dopamine levels induced by l-DOPA (50–100 μM) at 24 h. Catalponol at 2–5 μM inhibited l-DOPA (100–200 μM)-induced cytotoxicity at 48 h. These results suggest that 1 enhanced dopamine biosynthesis by inducing TH activity and protected against l-DOPA-induced cytotoxicity in PC12 cells, which was mediated by the increased levels of cyclic AMP.

[1]  Myung-Koo Lee,et al.  Effects of scoparone on dopamine biosynthesis and L‐DOPA‐induced cytotoxicity in PC12 cells , 2009, Journal of neuroscience research.

[2]  Myung-Koo Lee,et al.  Induction of dopamine biosynthesis by l-DOPA in PC12 cells: implications of L-DOPA influx and cyclic AMP. , 2008, European journal of pharmacology.

[3]  Myung-Koo Lee,et al.  Effects of catalpalactone on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells. , 2008, Environmental toxicology and pharmacology.

[4]  Luciana Parisi,et al.  Biotech , 2007, Bollettino chimico farmaceutico.

[5]  L. Costa-Lotufo,et al.  Bioactivity of Biflorin, a Typical o-Naphthoquinone Isolated from Capraria biflora L. , 2005, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[6]  Jae Joon Lee,et al.  Enantio-selective inhibition of (1R,9S)- and (1S,9R)-β-hydrastines on dopamine biosynthesis in PC12 cells , 2004, Neuropharmacology.

[7]  Y. Surh,et al.  Potentiation of cellular antioxidant capacity by Bcl-2: implications for its antiapoptotic function. , 2003, Biochemical pharmacology.

[8]  B. Kronenberger,et al.  Cyclic AMP Induces Transactivation of the Receptors for Epidermal Growth Factor and Nerve Growth Factor, Thereby Modulating Activation of MAP Kinase, Akt, and Neurite Outgrowth in PC12 Cells* , 2002, The Journal of Biological Chemistry.

[9]  Johannes Schwarz,et al.  Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter. , 2002, Biochemical pharmacology.

[10]  Y. Kato,et al.  Effects of dopamine and L‐DOPA on survival of PC12 cells , 2000, Journal of neuroscience research.

[11]  Myung-Koo Lee,et al.  Inhibition of Dopamine Biosynthesis by Protoberberine Alkaloids in PC12 Cells , 2000, Neurochemical Research.

[12]  L. Sciola,et al.  Enhancing Effect of Manganese on L‐DOPA‐Induced Apoptosis in PC12 Cells , 1999, Journal of neurochemistry.

[13]  S. Bataillé,et al.  Protective effect of neurotrophic factors, neuropoietic cytokines and dibutyryl cyclic amp on hydrogen peroxide-induced cytotoxicity on PC12 cells: a possible link with the state of differentiation , 1998, Neurochemistry International.

[14]  A. Barzilai,et al.  Levodopa induces apoptosis in cultured neuronal cells—A possible accelerator of nigrostriatal degeneration in Parkinson's disease? , 1997, Movement disorders : official journal of the Movement Disorder Society.

[15]  C. Marsden,et al.  Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine , 1996, Neuroscience Letters.

[16]  C. Waters,et al.  Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease. , 1995, The Journal of clinical investigation.

[17]  H. M. Geller,et al.  l‐DOPA Cytotoxicity to PC12 Cells in Culture Is via Its Autoxidation , 1995, Journal of neurochemistry.

[18]  D. H. Park,et al.  A dual role for the cAMP-dependent protein kinase in tyrosine hydroxylase gene expression. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[20]  T. Kato,et al.  A new and highly sensitive voltammetric assay for aromatic L-amino acid decarboxylase activity by high-performance liquid chromatography. , 1979, Analytical biochemistry.

[21]  C. C. Chen,et al.  [Quinones and related compounds in higher plants. VII. Supplementary studies on the constituents of the wood of Catalpa ovata (author's transl)]. , 1979, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[22]  L. Greene,et al.  Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheochromocytoma cells , 1977, Brain Research.

[23]  T. Okuda,et al.  Two new flavone glycosides from Catalpa ovata , 1975 .

[24]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[25]  T. Shafer,et al.  Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies. , 1991, Neurotoxicology.

[26]  H. Nohta,et al.  High-performance liquid chromatography of plasma catecholamines using 1,2-diphenylethylenediamine as precolumn fluorescence derivatization reagent. , 1985, Journal of chromatography.

[27]  S. Ueda,et al.  Quinones and related compounds in higher plants. Part 11. Role of 2-carboxy-2,3-dihydro-1,4-naphthoquinone and 2-carboxy-2-(3-methyl-but-2-enyl)-2,3-dihydro-1,4-naphthoquinone in the biosynthesis of naphthoquinone congeners of Catalpa ovata callus tissues , 1981 .